ABNX — Abionyx Pharma SA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Abionyx Pharma SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	9.15	7.93	4.05	4.1	3.23
Net Total Accounts Receivable
Net Total Receivables	0.841	4.62	3.05	2.5	2.29
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	10	13	7.57	6.89	5.86
Net Property, Plant And Equipment	0.115	3.07	2.56	2.21	1.98
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	10.3	21.8	15.8	14.8	13.5
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.6	6.75	5.09	3.92	3.71
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	3.66	11.2	8.65	6.91	6.03
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	6.63	10.7	7.17	7.92	7.51
Total Liabilities & Shareholders' Equity	10.3	21.8	15.8	14.8	13.5
Total Common Shares Outstanding